BlueWhale Bio
About:
BlueWhale Bio is committed to advancing cell-based therapeutics through manufacturing innovation.
Website: https://bluewhale.bio
Top Investors: Marshall Wace, Novalis LifeSciences, Danaher Ventures
Description:
BlueWhale Bio is spinout from the University of Pennsylvania to accelerate the use of cell-based therapies by manufacturing innovation.
Total Funding Amount:
$18M
Headquarters Location:
Philadelphia, Pennsylvania, United States
Founded Date:
2022-01-01
Contact Email:
careers(AT)bluewhale.bio
Founders:
Carl June, Peter Keller
Number of Employees:
11-50
Last Funding Date:
2023-09-07
IPO Status:
Private
Industries:
© 2025 bioDAO.ai